Dr. Lin Kong
✓ Available through China Expert Care
Assistant President; Director, Department of Head and Neck and Central Nervous System Tumors I; Chief Physician and Doctoral Supervisor
Department of Head and Neck and Central Nervous System Tumors, Shanghai Proton and Heavy Ion Center

Focus: Proton and carbon ion therapy for head and neck cancers, including recurrent nasopharyngeal cancer, and brain tumours
Dr. Kong is Assistant President of Shanghai Proton and Heavy Ion Center and leads one of its head and neck and central nervous system tumour departments. First author of phase I/II trials of carbon ion radiotherapy, alone and with chemotherapy, for locally recurrent nasopharyngeal cancer, and of the centre's early experience with particle therapy for malignant glioma.
Conditions: Proton and carbon ion therapy, Nasopharyngeal cancer
Selected publications
- Journal of Cancer, 2016 (first author): Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma. PubMed 27162535
- Chinese Journal of Cancer, 2016 (first author): Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma. PubMed 28007028
- Cancer, 2020 (first author): Particle radiation therapy in the management of malignant glioma: Early experience at the Shanghai Proton and Heavy Ion Center. PubMed 32167589
Profile on the hospital website: https://www.sphic.org.cn/lcystd/info_9.aspx?itemid=43
Request a written opinion from Dr. Lin Kong
Send your records. A medical coordinator will reply within 24 hours.
Start here